Donor-Derived Cell-Free DNA for Acute Rejection Monitoring in Heart and Lung Transplantation

PURPOSE OF REVIEW: Acute allograft rejection is a common cause of morbidity and mortality in heart and lung transplantation. Unfortunately, the current monitoring gold standard—biopsy plus histopathology—has several limitations. Plasma donor-derived cell-free DNA (dd-cfDNA) has emerged as a potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Keller, Michael, Agbor-Enoh, Sean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Thoracic Transplantation (J Patel and AM Holm, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570240/
https://www.ncbi.nlm.nih.gov/pubmed/34754720
http://dx.doi.org/10.1007/s40472-021-00349-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570240/
https://www.ncbi.nlm.nih.gov/pubmed/34754720
http://dx.doi.org/10.1007/s40472-021-00349-8

Ejemplares similares